This ADC product is composed of an anti-fibronectin antibody (clone F8) conjugated via linker to DM1-SH (F8-SIP-DM1-SH). It has demonstrated a response in murine F9 teratocarcinomas treatment by a MOA (Mechanism of Action) of microtubules depolymerizing.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.